Genetics of plasma dopamine beta-hydroxylase activity in schizophrenia
Genetics of plasma dopamine beta-hydroxylase activity in schizophrenia
批准号:
7559504
负责人:
Joseph F. Cubells
金额:
$43.04万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-02-28 至 2011-01-31
关键词:
19pAffectAllelesAmericanArchivesBiochemicalBiological AssayChromosomesCollectionCriminal JusticeDNADetectionDevelopmentDiagnosisDisabled PersonsDiseaseDopamineDopamine-beta-monooxygenaseEuropeanFamilyFreezingGene-ModifiedGeneticGenetic ResearchGenomeGenotypeHaplotypesHealthcareHomoHumanIndividualInterventionKineticsMeasurementMeasuresMolecularNorepinephrineOutcomePatientsPatternPhenotypePlasmaPredispositionProductivityProteinsPsychopathologyPublic HealthQuantitative Trait LociRegulationRelative (related person)Research PersonnelSamplingSchizophreniaShort-Term MemorySocietiesStagingStructural GenesSymptomsSystemTestingTimeVariantWorkbaseconditioningcostenzyme activityfollow-upgenetic associationgenetic linkage analysisgenetic pedigreegenome-wide linkagemolecular markerprobandprogramsprotein degradationtransmission process
中文摘要
性状(申请人提供):多巴胺β-羟化酶(DbH)将多巴胺(DA)转化为去甲肾上腺素(NE),可在血浆中测定,其活性受寡基因机制的遗传控制。虽然连锁研究的基础上的表型标记,和分子关联研究,表明结构基因DBH是一个主要的数量性状基因座调节血浆DbH活性,这一假设从来没有被测试的分子连锁分析。有证据表明,至少有一个额外的基因座有助于调节血浆DbH活性,但该基因座的身份是未知的。确定负责调节血浆DbH的基因座对于精神分裂症(SCZ)的遗传研究是重要的,因为几条证据表明,血浆DbH活性的差异与SCZ的表型表现的差异有关。此外,大量证据表明,DA和NE介导的神经传递的改变影响与SCZ精神病理学相关的核心表型,如执行记忆和工作记忆。因此,我们假设DBH是SCZ中的修饰基因,与易感基因座相互作用以改变疾病的症状和病程。本申请提出了4个目的:(1)在一组可获得血浆样品的SCZ家系中进行血浆DbH活性的连锁分析;(2)进行该连锁研究的后续关联分析以鉴定负责调节血浆DbH的基因座和特定变体;(3)在更大的SCZ家系集合中进行SCZ的连锁分析,条件是已经确定的与血浆DbH活性强烈相关的DBH处的2个SNP的基因型;(4)在这些家系的先证者中进行关联分析,以检验DbH调节SNP与改变的症状特征和病程相关的假设。这项拟议中的工作对公共卫生具有重要意义,因为SCZ是一种常见的疾病,通常会使人们在进入成年后致残,导致生产力的巨大成本,医疗保健和刑事司法系统的巨大负担,以及患者及其家人的巨大痛苦。确定SCZ不同结果的预测因子将为制定有针对性的干预措施开辟新的途径,这些干预措施可以显着改善SCZ对个人和社会的影响。
英文摘要
DESCRIPTION (provided by applicant): Dopamine beta-hydroxylase (DbH) converts dopamine (DA) to norepinephrine (NE), and can be assayed in the plasma, where its activity is under genetic control by an oligogenic mechanism. While linkage studies based on phenotypic markers, and molecular association studies, suggest the structural gene DBH is a major quantitative trait locus regulating plasma DbH activity, this hypothesis has never been tested by molecular linkage analysis. There is evidence for at least one additional locus contributing to the regulation of plasma DbH activity, but the identity of this locus is unknown. Identifying the loci responsible for regulating plasma DbH is important for genetic research on schizophrenia (SCZ), because several lines of evidence suggest that differences in plasma DbH activity associate with differences in the phenotypic presentation of SCZ. In addition, abundant evidence suggests that alteration in DA- and NE-medicated neuro-transmission influence core phenotypes relevant to SCZ psychopathology, such as executive and working memory. We therefore hypothesize that DBH is a modifying gene in SCZ, that interacts with susceptibility loci to alter the symptoms and course of the illness. This application proposes 4 aims: (1) to conduct linkage analysis of plasma DbH activity in a set of SCZ pedigrees from which plasma samples are available; (2) to conduct follow-up association analysis of that linkage study to identify loci and specific variants responsible for regulating plasma DbH; (3) to conduct a linkage analysis of SCZ in a larger collection of SCZ families, conditional on genotypes at 2 SNPs at DBH already established to associate strongly with plasma DbH activity; and (4) to conduct association analyses in the probands of those families to test the hypothesis that DbH-regulating SNPs associate with altered symptomatic profiles and course of illness. The proposed work is significant for the public health because SCZ is a common disorder that usually disables people just as they enter adulthood, leading to huge costs in productivity, large burdens on healthcare and criminal-justice systems, and enormous human suffering by patients and their families. Identifying predictors of varying outcomes in SCZ would open new avenues for development of targeted interventions that could significantly ameliorate the impact of SCZ on individuals and society.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1007/s11920-011-0183-5
发表时间:
2011-04
期刊:
CURRENT PSYCHIATRY REPORTS
影响因子:
6.7
作者:
[Moreno-De-Luca, Daniel, Cubells, Joseph F.]
通讯作者:
Cubells, Joseph F.
A head-to-head comparison of risperidone and divalproex for treatment of pediatric bipolar disorder.
DOI:
10.1007/s11920-011-0182-6
发表时间:
2011-04
期刊:
CURRENT PSYCHIATRY REPORTS
影响因子:
6.7
作者:
[Cubells, Joseph F.]
通讯作者:
Cubells, Joseph F.
Psychosis-related Physiological and Neuronal Phenotypes in 22q11 Deletion Syndrome
-
批准号:10468740
-
项目类别:
-
资助金额:$64.84万
-
财政年份:2019
-
负责人:Joseph F. Cubells
-
依托单位:
Psychosis-related Physiological and Neuronal Phenotypes in 22q11 Deletion Syndrome
-
批准号:10670277
-
项目类别:
-
资助金额:$65.58万
-
财政年份:2019
-
负责人:Joseph F. Cubells
-
依托单位:
Psychosis-related Physiological and Neuronal Phenotypes in 22q11 Deletion Syndrome
-
批准号:10238027
-
项目类别:
-
资助金额:$69.37万
-
财政年份:2019
-
负责人:Joseph F. Cubells
-
依托单位:
Psychosis-related Physiological and Neuronal Phenotypes in 22q11 Deletion Syndrome
-
批准号:10005473
-
项目类别:
-
资助金额:$70.91万
-
财政年份:2019
-
负责人:Joseph F. Cubells
-
依托单位:
Translational analysis of functional variation in human dopamine beta?hydroxylase
-
批准号:8298987
-
项目类别:
-
资助金额:$19.17万
-
财政年份:2011
-
负责人:Joseph F. Cubells
-
依托单位:
Translational analysis of functional variation in human dopamine beta?hydroxylase
-
批准号:8191158
-
项目类别:
-
资助金额:$23.04万
-
财政年份:2011
-
负责人:Joseph F. Cubells
-
依托单位:
Genetic Modulators of HPA-Axis Regulation, Stress Sensitivity
-
批准号:8111194
-
项目类别:
-
资助金额:$23.77万
-
财政年份:2010
-
负责人:Joseph F. Cubells
-
依托单位:
Secondary Research Project: Genetics
-
批准号:8119600
-
项目类别:
-
资助金额:$15.39万
-
财政年份:2010
-
负责人:Joseph F. Cubells
-
依托单位:
Genetic Modulators of HPA-Axis Regulation, Stress Sensitivity
-
批准号:7931867
-
项目类别:
-
资助金额:$24.18万
-
财政年份:2009
-
负责人:Joseph F. Cubells
-
依托单位:
Secondary Research Project: Genetics
-
批准号:7892512
-
项目类别:
-
资助金额:$14.42万
-
财政年份:2009
-
负责人:Joseph F. Cubells
-
依托单位:
Secondary Research Project: Genetics
-
批准号:7645105
-
项目类别:
-
资助金额:$14.32万
-
财政年份:2008
-
负责人:Joseph F. Cubells
-
依托单位:
Pharmacogenetics Core
-
批准号:7648024
-
项目类别:
-
资助金额:$42.42万
-
财政年份:2008
-
负责人:Joseph F. Cubells
-
依托单位:
Pharmacogenetics Core
-
批准号:7514102
-
项目类别:
-
资助金额:$29.09万
-
财政年份:2007
-
负责人:Joseph F. Cubells
-
依托单位:
Genetics of plasma dopamine beta-hydroxylase activity in schizophrenia
-
批准号:7213761
-
项目类别:
-
资助金额:$51.56万
-
财政年份:2007
-
负责人:Joseph F. Cubells
-
依托单位:
Pharmacogenetics Core
-
批准号:6830597
-
项目类别:
-
资助金额:$17.48万
-
财政年份:2004
-
负责人:Joseph F. Cubells
-
依托单位:
Human Genetics of Drug-Abuse Related Phenotypes
-
批准号:6560033
-
项目类别:
-
资助金额:$11.71万
-
财政年份:2003
-
负责人:Joseph F. Cubells
-
依托单位:
Human Genetics of Drug-Abuse Related Phenotypes
-
批准号:6926290
-
项目类别:
-
资助金额:$12.17万
-
财政年份:2003
-
负责人:Joseph F. Cubells
-
依托单位:
Human Genetics of Drug-Abuse Related Phenotypes
-
批准号:7106607
-
项目类别:
-
资助金额:$12.17万
-
财政年份:2003
-
负责人:Joseph F. Cubells
-
依托单位:
Human Genetics of Drug-Abuse Related Phenotypes
-
批准号:7250924
-
项目类别:
-
资助金额:$12.17万
-
财政年份:2003
-
负责人:Joseph F. Cubells
-
依托单位:
Human Genetics of Drug-Abuse Related Phenotypes
-
批准号:6734225
-
项目类别:
-
资助金额:$12.32万
-
财政年份:2003
-
负责人:Joseph F. Cubells
-
依托单位:
海外基金